Description
TRIMVIS
is a corticosteroid medication manufactured by ANVIS, containing Triamcinolone BP in tablet form. Each box includes 3 strips of 10 tablets. It is formulated to treat a range of inflammatory and allergic skin conditions.
Pharmacological class:
- Corticosteroid (Glucocorticoid)
Mechanism of action:
Triamcinolone reduces inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability. It inhibits inflammatory mediators, thereby relieving redness, itching, and swelling.
Indications:
- Allergic skin reactions
- Dermatitis and eczema
- Burning, itching, and redness of the skin
- Small white or red bumps (papular eruptions)
- Autoimmune skin conditions (under physician supervision)
Benefits:
- Rapid anti-inflammatory and anti-allergic effect
- Relief from itching, burning, and redness
- Promotes healing of minor skin eruptions
- Oral tablet form for systemic treatment
Packaging:
- Box contains 3 strips x 10 tablets (total 30 tablets)
Safety notes:
- Use only under medical supervision
- Long-term use may cause adrenal suppression
- Not recommended for fungal or viral skin infections
- May require tapering to avoid withdrawal
Market positioning:
Compared to topical corticosteroids, TRIMVIS offers systemic relief for widespread or severe skin inflammation. It is suitable for patients who do not respond to topical therapy or require internal anti-inflammatory action
